European equities traded mostly in positive territory on Monday after U.S. President Donald Trump struck a less confrontational tone on trade relations with Beijing, saying that everything would be “fine” and that Washington was not aiming to “hurt” China.
Investor sentiment also centered on France, where Prime Minister Sébastien Lecornu, reappointed last Friday, unveiled his new cabinet amid growing concerns over budgetary pressures that have unsettled both businesses and investors.
Economic news was limited, though data from Destatis indicated that wholesale inflation in Germany continued to accelerate in September. Wholesale prices rose 1.2% year-on-year, up from a 0.7% increase in August and 0.5% in July.
Major European indexes were mixed but leaned upward: Germany’s DAX and France’s CAC 40 both climbed 0.2%, while the U.K.’s FTSE 100 dipped 0.1%, bucking the broader trend.
In corporate news, shares of PSI Software (TG:PSAN) surged after private equity firm Warburg Pincus announced plans for a voluntary public takeover valued at more than €700 million.
French fintech Sidetrade (EU:ALBFR) also rallied after signing binding agreements to acquire 100% of EzyCollect.
Exosens (EU:EXENS) rose sharply following news that Theon International Plc (EU:THEON) intends to purchase a 9.8% stake in the company for €268.7 million.
Swedish construction firm Skanska (USOTC:SKBSY) gained after securing a $175 million (approximately SEK 1.7 billion) contract with Ridgeline Development Partners to build a residential and hotel complex in downtown Nashville, Tennessee.
Dutch neurotechnology company Onward Medical (EU:ONWD) advanced after delivering its Q3 2025 business update, while British retailer Pets at Home (LSE:PETS) moved higher after launching the second phase of its £25 million share buyback program.
In contrast, shares of AstraZeneca (LSE:AZN) declined after the pharmaceutical group became the second company to strike a deal with the Trump administration to lower drug prices in exchange for tariff relief.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.
Leave a Reply